Concerning CB2, previous evidence from other laboratories pointed out at the possible role of CB2 in modulating microglial activation in different neurodegenerative disorders such as AD [12, 16], so we explored whether the up-regulatory response experienced by CB2 receptors in our tauopathy model could have any relation with the inflammatory response. Here, CNR2 is linked to Alzheimer disease.